You Ready For The Financial Fireworks This Week? $NVDA $CRM $BBY $DELL $LULU $INDP

By John F. Heerdink, Jr.

Get ready for a week of financial fireworks as the stock market’s version of a reality TV show unfolds! First up on the stage is the chip-making superstar, Nvidia (NVDA), set to drop its earnings report after the bell on Wednesday. Investors are on the edge of their seats, wondering if Nvidia’s results will be as dazzling as a tech-themed Broadway show or if it will leave them feeling like they just watched a low-budget sci-fi flick.

But wait, there’s more! The earnings extravaganza doesn’t stop with Nvidia. Salesforce (CRM), Best Buy (BBY), Dell (DELL), and Lululemon (LULU) are also preparing to share their financial tales. Will Salesforce’s earnings be a cloud-nine experience, or will it need a rain check? Can Best Buy prove it’s still the best place to buy gadgets, or will it be more like “Best Try”? And what about Dell—will it deliver a performance as smooth as its laptops, or will it crash like an old hard drive? Meanwhile, Lululemon is hoping its earnings aren’t as stretchy as its yoga pants.

As if that weren’t enough to keep the financial world buzzing, the Federal Reserve’s favorite inflation gauge is also set to make an appearance on the economic calendar. Will it reveal that inflation is cooling off like a summer breeze, or will it be as hot as a jalapeño pepper? Investors will be watching closely, hoping for a number that doesn’t make them sweat bullets.

So grab your popcorn and get ready for a week of earnings drama, where every report is a potential plot twist and the market’s mood swings faster than a caffeinated squirrel!

Sources

[1] Buy Or Sell Nvidia Before It Reports Earnings… – YouTube https://www.youtube.com/watch?v=9okQbbfG4oQ

[2] Earnings week ahead: NVIDIA, CrowdStrike, Salesforce, Lululemon … https://seekingalpha.com/news/4143309-earnings-week-ahead-nvidia-crowdstrike-salesforce-lululemon-and-more

[3] Take Five: Nvidia, let’s see what you’ve got | 1330 & 101.5 WHBL https://whbl.com/2024/08/23/take-five-nvidia-lets-see-what-youve-got/

[4] Forget Nvidia. This AI Powerhouse Demands A Look Right Now. https://www.investors.com/research/breakout-stocks-technical-analysis/salesforce-crm-stock-nvidia-microsoft-meta-google/

[5] Tech Earnings Preview: Nvidia, Salesforce, And HP In Focus https://www.barchart.com/story/news/28186070/tech-earnings-preview-nvidia-salesforce-and-hp-in-focus

[6] Earnings Whispers on X: “The most anticipated earnings releases … https://twitter.com/eWhispers/status/1827847061242311018

READY TO LEARN MORE TODAY?

Learn more about an innovative “Pulse Prime” approach with Roger Waltzman, Chief Medical Officer at Indaptus Therapeutics (NASDAQ: INDP), as he explains how their novel therapy, Decoy20, and how it is set to potentially revolutionize cancer treatment. This method involves administering a rapid, potent dose of engineered bacteria directly into the bloodstream—unlike traditional therapies, this “pulse” is brief yet effective enough to activate and prime the immune system without the prolonged exposure that can lead to side effects. This intermittent dosing strategy aims to enhance the immune system’s responsiveness and reduce potential adverse reactions, offering new hope to more patients battling advanced cancer. Watch to learn more about how we’re harnessing the body’s defenses to fight cancer more effectively.

View this brief video below to learn more now: